The essential roles of Toll-like receptor signaling pathways in sterile inflammatory diseases

International Immunopharmacology

Volumn 11, Issue 10, 2011, Pages 1422-1432

  Lin, Qing ^a   Li, Mingcai ^b   Fang, Dan ^a   Fang, Jiazhu ^a   Su, Shao Bo ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b NINGBO UNIVERSITY   (China)

Author keywords

Autoimmunity; Ligands; Sterile inflammation; Toll like receptors

Indexed keywords

BETA INTERFERON; CPG OLIGODEOXYNUCLEOTIDE; HIGH MOBILITY GROUP B1 PROTEIN; INTERFERON REGULATORY FACTOR 3; MYELOID DIFFERENTIATION FACTOR 88; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 11; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 2; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ALLERGIC ENCEPHALITIS; ALZHEIMER DISEASE; AUTOIMMUNE DISEASE; CONFORMATIONAL TRANSITION; CYTOKINE PRODUCTION; ENDOTOXIN INDUCED UVEITIS; EXPERIMENTAL AUTOIMMUNE UVEITIS; HEPATITIS; HUMAN; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; KIDNEY INJURY; LUNG INJURY; MOLECULAR RECOGNITION; MYOCARDITIS; NEUROPATHIC PAIN; NONHUMAN; OLIGOMERIZATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; REPERFUSION INJURY; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SKIN INJURY; SYSTEMIC LUPUS ERYTHEMATOSUS; TISSUE REGENERATION; TISSUE REPAIR; UVEITIS; VASCULARIZATION; WOUND HEALING;

ADAPTIVE IMMUNITY; ANIMALS; AUTOANTIGENS; AUTOIMMUNE DISEASES; HUMANS; IMMUNITY, INNATE; MOLECULAR TARGETED THERAPY; REGENERATION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS; WOUND HEALING;

EID: 80053221916     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2011.04.026     Document Type: Review

References (171)

1. F.Y. Liew, D. Xu, E.K. Brint, and L.A. O'Neill Negative regulation of Toll-like receptor-mediated immune responses Nat Rev Immunol 5 2005 446 458 (Pubitemid 40835033)
2. K. Takeda, and S. Akira Toll-like receptors in innate immunity Int Immunol 17 2005 1 14
3. F. Brentano, D. Kyburz, O. Schorr, R. Gay, and S. Gay The role of Toll-like receptor signalling in the pathogenesis of arthritis Cell Immunol 233 2005 90 96 (Pubitemid 41074060)
4. I.R. Rifkin, E.A. Leadbetter, L. Busconi, G. Viglianti, and A. Marshak-Rothstein Toll-like receptors, endogenous ligands, and systemic autoimmune disease Immunol Rev 204 2005 27 42 (Pubitemid 40460491)
5. L. Yu, L. Wang, and S. Chen Endogenous Toll-like receptor ligands and their biological significance J Cell Mol Med 14 2010 2592 2603
6. F.J. Sheedy, and L.A. O'Neill The Troll in Toll: Mal and Tram as bridges for TLR2 and TLR4 signaling J Leukoc Biol 82 2007 196 203 (Pubitemid 47230627)
7. S. Akira, S. Uematsu, and O. Takeuchi Pathogen recognition and innate immunity Cell 124 2006 783 801 (Pubitemid 43261452)
8. K. Takeda, T. Kaisho, and S. Akira Toll-like receptors Annu Rev Immunol 21 2003 335 376 (Pubitemid 37174535)
9. K.J. Ishii, S. Uematsu, and S. Akira 'Toll' gates for future immunotherapy Curr Pharm Des 12 2006 4135 4142
10. E. Latz, A. Verma, A. Visintin, M. Gong, C.M. Sirois, and D.C. Klein Ligand-induced conformational changes allosterically activate Toll-like receptor 9 Nat Immunol 8 2007 772 779 (Pubitemid 46965353)
11. C.R. Stewart, L.M. Stuart, K. Wilkinson, J.M. van Gils, J. Deng, and A. Halle CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer Nat Immunol 11 2010 155 161
12. N.J. Gay, and M. Gangloff Structure and function of Toll receptors and their ligands Annu Rev Biochem 76 2007 141 165
13. L.A. O'Neill How Toll-like receptors signal: what we know and what we don't know Curr Opin Immunol 18 2006 3 9 (Pubitemid 43049641)
14. D.M. Underhill Collaboration between the innate immune receptors dectin-1, TLRs, and Nods Immunol Rev 219 2007 75 87 (Pubitemid 47390003)
15. P.J. Crack, and P.J. Bray Toll-like receptors in the brain and their potential roles in neuropathology Immunol Cell Biol 85 2007 476 480 (Pubitemid 47367513)
16. S. Akira, and K. Takeda Toll-like receptor signalling Nat Rev Immunol 4 2004 499 511 (Pubitemid 38931765)
17. L.A. O'Neill, and A.G. Bowie The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling Nat Rev Immunol 7 2007 353 364 (Pubitemid 46674493)
18. K. Chen, J. Huang, W. Gong, P. Iribarren, N.M. Dunlop, and J.M. Wang Toll-like receptors in inflammation, infection and cancer Int Immunopharmacol 7 2007 1271 1285 (Pubitemid 47126372)
19. T. Kawai, and S. Akira TLR signaling Semin Immunol 19 2007 24 32 (Pubitemid 46498752)
20. K. Takeda, and S. Akira TLR signaling pathways Semin Immunol 16 2004 3 9 (Pubitemid 38147427)
21. K.A. Fitzgerald, E.M. Palsson-McDermott, A.G. Bowie, C.A. Jefferies, A.S. Mansell, and G. Brady Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction Nature 413 2001 78 83 (Pubitemid 32843491)
22. A. Mansell, R. Smith, S.L. Doyle, P. Gray, J.E. Fenner, and P.J. Crack Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation Nat Immunol 7 2006 148 155 (Pubitemid 43135880)
23. A. Iwasaki, and R. Medzhitov Toll-like receptor control of the adaptive immune responses Nat Immunol 5 2004 987 995 (Pubitemid 41057715)
24. D.N. Cook, D.S. Pisetsky, and D.A. Schwartz Toll-like receptors in the pathogenesis of human disease Nat Immunol 5 2004 975 979 (Pubitemid 41057713)
25. M.F. Roelofs, W.C. Boelens, L.A. Joosten, S. Abdollahi-Roodsaz, J. Geurts, and L.U. Wunderink Identification of small heat shock protein B8 (HSP22) as a novel TLR4 ligand and potential involvement in the pathogenesis of rheumatoid arthritis J Immunol 176 2006 7021 7027 (Pubitemid 43787883)
26. K.W. Kim, M.L. Cho, S.H. Lee, H.J. Oh, C.M. Kang, and J.H. Ju Human rheumatoid synovial fibroblasts promote osteoclastogenic activity by activating RANKL via TLR-2 and TLR-4 activation Immunol Lett 110 2007 54 64 (Pubitemid 46695759)
27. S.M. Sacre, E. Andreakos, S. Kiriakidis, P. Amjadi, A. Lundberg, and G. Giddins The Toll-like receptor adaptor proteins MyD88 and Mal/TIRAP contribute to the inflammatory and destructive processes in a human model of rheumatoid arthritis Am J Pathol 170 2007 518 525 (Pubitemid 47339389)
28. S.J. Moon, M.K. Park, H.J. Oh, S.Y. Lee, S.K. Kwok, and M.L. Cho Engagement of Toll-like receptor 3 induces vascular endothelial growth factor and interleukin-8 in human rheumatoid synovial fibroblasts Korean J Intern Med 25 2010 429 435
29. L. Meng, W. Zhu, C. Jiang, X. He, W. Hou, and F. Zheng Toll-like receptor 3 upregulation in macrophages participates in the initiation and maintenance of pristane-induced arthritis in rats Arthritis Res Ther 12 2010 R103
30. B.S. Hansen, R.Z. Hussain, A.E. Lovett-Racke, J.A. Thomas, and M.K. Racke Multiple Toll-like receptor agonists act as potent adjuvants in the induction of autoimmunity J Neuroimmunol 172 2006 94 103 (Pubitemid 43277494)
31. M. Prinz, F. Garbe, H. Schmidt, A. Mildner, I. Gutcher, and K. Wolter Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis J Clin Invest 116 2006 456 464 (Pubitemid 43228363)
32. L. Visser, H. Jan de Heer, L.A. Boven, D. van Riel, M. van Meurs, and M.J. Melief Proinflammatory bacterial peptidoglycan as a cofactor for the development of central nervous system autoimmune disease J Immunol 174 2005 808 816 (Pubitemid 40094276)
33. N.A. Wolf, T.K. Amouzegar, and R.H. Swanborg Synergistic interaction between Toll-like receptor agonists is required for induction of experimental autoimmune encephalomyelitis in Lewis rats J Neuroimmunol 185 2007 115 122 (Pubitemid 46497453)
34. T. Touil, D. Fitzgerald, G.X. Zhang, A. Rostami, and B. Gran Cutting edge: TLR3 stimulation suppresses experimental autoimmune encephalomyelitis by inducing endogenous IFN-beta J Immunol 177 2006 7505 7509 (Pubitemid 44846263)
35. C. Jack, F. Ruffini, A. Bar-Or, and J.P. Antel Microglia and multiple sclerosis J Neurosci Res 81 2005 363 373 (Pubitemid 41359291)
36. T.L. Sorensen, C. Trebst, P. Kivisakk, K.L. Klaege, A. Majmudar, and R. Ravid Multiple sclerosis: a study of CXCL10 and CXCR3 co-localization in the inflamed central nervous system J Neuroimmunol 127 2002 59 68 (Pubitemid 34603575)
37. E.J. Downer, E. Clifford, B. Gran, H.J. Nel, P.G. Fallon, and P.N. Moynagh Identification of the synthetic cannabinoid R(+)WIN55,212-2 as a novel regulator of IFN regulatory factor 3 (IRF3) activation and IFN-{beta} expression: relevance to therapeutic effects in models of multiple sclerosis J Biol Chem 286 2011 10316 10328
38. M.F. Farez, F.J. Quintana, R. Gandhi, G. Izquierdo, M. Lucas, and H.L. Weiner Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE Nat Immunol 10 2009 958 964
39. U. Eriksson, R. Ricci, L. Hunziker, M.O. Kurrer, G.Y. Oudit, and T.H. Watts Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity Nat Med 9 2003 1484 1490 (Pubitemid 38004775)
40. B.J. Marsland, C. Nembrini, K. Grun, R. Reissmann, M. Kurrer, and C. Leipner TLR ligands act directly upon T cells to restore proliferation in the absence of protein kinase C-theta signaling and promote autoimmune myocarditis J Immunol 178 2007 3466 3473 (Pubitemid 46417611)
41. P.P. Pagni, S. Traub, O. Demaria, L. Chasson, and L. Alexopoulou Contribution of TLR7 and TLR9 signaling to the susceptibility of MyD88-deficient mice to myocarditis Autoimmunity 43 2010 275 287
42. K. Ojiro, H. Ebinuma, N. Nakamoto, K. Wakabayashi, Y. Mikami, and Y. Ono MyD88-dependent pathway accelerates the liver damage of Concanavalin A-induced hepatitis Biochem Biophys Res Commun 399 2010 744 749
43. H. Zhang, Q. Gong, J.H. Li, X.L. Kong, L. Tian, and L.H. Duan CpG ODN pretreatment attenuates concanavalin A-induced hepatitis in mice Int Immunopharmacol 10 2010 79 85
44. V. Stadlbauer, R.P. Mookerjee, G.A. Wright, N.A. Davies, G. Jurgens, and S. Hallstrom Role of Toll-like receptors 2, 4, and 9 in mediating neutrophil dysfunction in alcoholic hepatitis Am J Physiol Gastrointest Liver Physiol 296 2009 G15 G22
45. H.J. Anders, and D. Schlondorff Toll-like receptors: emerging concepts in kidney disease Curr Opin Nephrol Hypertens 16 2007 177 183 (Pubitemid 46608524)
46. N. Tsuboi, Y. Yoshikai, S. Matsuo, T. Kikuchi, K. Iwami, and Y. Nagai Roles of Toll-like receptors in C - C chemokine production by renal tubular epithelial cells J Immunol 169 2002 2026 2033 (Pubitemid 34857667)
47. H.J. Brown, S.H. Sacks, and M.G. Robson Toll-like receptor 2 agonists exacerbate accelerated nephrotoxic nephritis J Am Soc Nephrol 17 2006 1931 1939 (Pubitemid 44036177)
48. S.A. Summers, B.S. van der Veen, K.M. O'Sullivan, P.Y. Gan, J.D. Ooi, and P. Heeringa Intrinsic renal cell and leukocyte-derived TLR4 aggravate experimental anti-MPO glomerulonephritis Kidney Int 78 2010 1263 1274
49. P. Yu, U. Wellmann, S. Kunder, L. Quintanilla-Martinez, L. Jennen, and N. Dear Toll-like receptor 9-independent aggravation of glomerulonephritis in a novel model of SLE Int Immunol 18 2006 1211 1219 (Pubitemid 44349296)
50. R.D. Pawar, A. Ramanjaneyulu, O.P. Kulkarni, M. Lech, S. Segerer, and H.J. Anders Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus J Am Soc Nephrol 18 2007 1721 1731 (Pubitemid 46870309)
51. L. Dong, S. Ito, K.J. Ishii, and D.M. Klinman Suppressive oligodeoxynucleotides delay the onset of glomerulonephritis and prolong survival in lupus-prone NZB × NZW mice Arthritis Rheum 52 2005 651 658 (Pubitemid 40216332)
52. S.R. Christensen, J. Shupe, K. Nickerson, M. Kashgarian, R.A. Flavell, and M.J. Shlomchik Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus Immunity 25 2006 417 428 (Pubitemid 44354217)
53. A. Lartigue, P. Courville, I. Auquit, A. Francois, C. Arnoult, and F. Tron Role of TLR9 in anti-nucleosome and anti-DNA antibody production in lpr mutation-induced murine lupus J Immunol 177 2006 1349 1354 (Pubitemid 44036642)
54. X. Wu, and S.L. Peng Toll-like receptor 9 signaling protects against murine lupus Arthritis Rheum 54 2006 336 342 (Pubitemid 43122217)
55. A. Benigni, C. Caroli, L. Longaretti, E. Gagliardini, C. Zoja, and M. Galbusera Involvement of renal tubular Toll-like receptor 9 in the development of tubulointerstitial injury in systemic lupus Arthritis Rheum 56 2007 1569 1578 (Pubitemid 46764086)
56. S.A. Summers, O.M. Steinmetz, J.D. Ooi, P.Y. Gan, K.M. O'Sullivan, and K. Visvanathan Toll-like receptor 9 enhances nephritogenic immunity and glomerular leukocyte recruitment, exacerbating experimental crescentic glomerulonephritis Am J Pathol 177 2010 2234 2244
57. A. Sadanaga, H. Nakashima, M. Akahoshi, K. Masutani, K. Miyake, and T. Igawa Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice Arthritis Rheum 56 2007 1618 1628 (Pubitemid 46764091)
58. L. Chen, T. Wang, P. Zhou, L. Ma, D. Yin, and J. Shen TLR engagement prevents transplantation tolerance Am J Transplant 6 2006 2282 2291 (Pubitemid 44359413)
59. T.R. Hawn, H. Wu, J.M. Grossman, B.H. Hahn, B.P. Tsao, and A. Aderem A stop codon polymorphism of Toll-like receptor 5 is associated with resistance to systemic lupus erythematosus Proc Natl Acad Sci U S A 102 2005 10593 10597 (Pubitemid 41061599)
60. P. Pisitkun, J.A. Deane, M.J. Difilippantonio, T. Tarasenko, A.B. Satterthwaite, and S. Bolland Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication Science 312 2006 1669 1672 (Pubitemid 43902669)
61. S. Subramanian, K. Tus, Q.Z. Li, A. Wang, X.H. Tian, and J. Zhou A Tlr7 translocation accelerates systemic autoimmunity in murine lupus Proc Natl Acad Sci U S A 103 2006 9970 9975 (Pubitemid 43993607)
62. M. Ehlers, H. Fukuyama, T.L. McGaha, A. Aderem, and J.V. Ravetch TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE J Exp Med 203 2006 553 561
63. S.R. Christensen, M. Kashgarian, L. Alexopoulou, R.A. Flavell, S. Akira, and M.J. Shlomchik Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus J Exp Med 202 2005 321 331 (Pubitemid 41043827)
64. P. Yu, P. Musette, and S.L. Peng Toll-like receptor 9 in murine lupus: more friend than foe! Immunobiology 213 2008 151 157 (Pubitemid 351164231)
65. S. Werwitzke, D. Trick, K. Kamino, T. Matthias, K. Kniesch, and B. Schlegelberger Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB × NZW)F1 mouse Arthritis Rheum 52 2005 3629 3638 (Pubitemid 41612234)
66. M. Ehlers, and J.V. Ravetch Opposing effects of Toll-like receptor stimulation induce autoimmunity or tolerance Trends Immunol 28 2007 74 79 (Pubitemid 46176735)
67. N. Giarratana, G. Penna, S. Amuchastegui, R. Mariani, K.C. Daniel, and L. Adorini A vitamin D analog down-regulates proinflammatory chemokine production by pancreatic islets inhibiting T cell recruitment and type 1 diabetes development J Immunol 173 2004 2280 2287 (Pubitemid 39063083)
68. F.J. Pirie, R. Pegoraro, A.A. Motala, S. Rauff, L. Rom, and T. Govender Toll-like receptor 3 gene polymorphisms in South African Blacks with type 1 diabetes Tissue Antigens 66 2005 125 130 (Pubitemid 41025934)
69. J. Tian, D. Zekzer, L. Hanssen, Y. Lu, A. Olcott, and D.L. Kaufman Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice J Immunol 167 2001 1081 1089 (Pubitemid 32660868)
70. F.J. Quintana, P. Carmi, and I.R. Cohen DNA vaccination with heat shock protein 60 inhibits cyclophosphamide-accelerated diabetes J Immunol 169 2002 6030 6035 (Pubitemid 35291711)
71. S. Devaraj, M.R. Dasu, S.H. Park, and I. Jialal Increased levels of ligands of Toll-like receptors 2 and 4 in type 1 diabetes Diabetologia 52 2009 1665 1668
72. S. Devaraj, I. Jialal, J.M. Yun, and A. Bremer Demonstration of increased Toll-like receptor 2 and Toll-like receptor 4 expression in monocytes of type 1 diabetes mellitus patients with microvascular complications Metabolism 60 2011 256 259
73. M. Jagannathan, M. McDonnell, Y. Liang, H. Hasturk, J. Hetzel, and D. Rubin Toll-like receptors regulate B cell cytokine production in patients with diabetes Diabetologia 53 2010 1461 1471
74. C.P. Hodgkinson, R.C. Laxton, K. Patel, and S. Ye Advanced glycation end-product of low density lipoprotein activates the Toll-like 4 receptor pathway implications for diabetic atherosclerosis Arterioscler Thromb Vasc Biol 28 2008 2275 2281
75. J. Li, C. Jin, J.C. Cleveland Jr., L. Ao, D. Xu, and D.A. Fullerton Enhanced inflammatory responses to Toll-like receptor 2/4 stimulation in type 1 diabetic coronary artery endothelial cells: the effect of insulin Cardiovasc Diabetol 9 2010 90
76. A. Aumeunier, F. Grela, A. Ramadan, L. Pham Van, E. Bardel, and A. Gomez Alcala Systemic Toll-like receptor stimulation suppresses experimental allergic asthma and autoimmune diabetes in NOD mice PLoS One 5 2010 e11484
77. S.J. Creely, P.G. McTernan, C.M. Kusminski, M. Fisher, N.F. Da Silva, and M. Khanolkar Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes Am J Physiol Endocrinol Metab 292 2007 E740 E747
78. D.M. Tsukumo, M.A. Carvalho-Filho, J.B. Carvalheira, P.O. Prada, S.M. Hirabara, and A.A. Schenka Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance Diabetes 56 2007 1986 1998 (Pubitemid 47195825)
79. F. Kim, M. Pham, I. Luttrell, D.D. Bannerman, J. Tupper, and J. Thaler Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity Circ Res 100 2007 1589 1596 (Pubitemid 46897262)
80. R.R. Caspi Th1 and Th2 responses in pathogenesis and regulation of experimental autoimmune uveoretinitis Int Rev Immunol 21 2002 197 208 (Pubitemid 34791940)
81. Z.Y. Wang, D. Yang, Q. Chen, C.A. Leifer, D.M. Segal, and S.B. Su Induction of dendritic cell maturation by pertussis toxin and its B subunit differentially initiate Toll-like receptor 4-dependent signal transduction pathways Exp Hematol 34 2006 1115 1124 (Pubitemid 44080388)
82. S.B. Su, P.B. Silver, P. Wang, C.C. Chan, and R.R. Caspi Dissociating the enhancing and inhibitory effects of pertussis toxin on autoimmune disease J Immunol 171 2003 2314 2319 (Pubitemid 37025536)
83. S.B. Su, P.B. Silver, M. Zhang, C.C. Chan, and R.R. Caspi Pertussis toxin inhibits induction of tissue-specific autoimmune disease by disrupting G protein-coupled signals J Immunol 167 2001 250 256 (Pubitemid 32567785)
84. J. Fang, D. Fang, P.B. Silver, F. Wen, B. Li, and X. Ren The role of TLR2, TRL3, TRL4, and TRL9 signaling in the pathogenesis of autoimmune disease in a retinal autoimmunity model Invest Ophthalmol Vis Sci 51 2010 3092 3099
85. X. Ren, H. Zhou, B. Li, and S.B. Su Toll-like receptor 3 ligand polyinosinic:polycytidylic acid enhances autoimmune disease in a retinal autoimmunity model Int Immunopharmacol 11 2011 769 773
86. S.B. Su, P.B. Silver, R.S. Grajewski, R.K. Agarwal, J. Tang, and C.C. Chan Essential role of the MyD88 pathway, but nonessential roles of TLRs 2, 4, and 9, in the adjuvant effect promoting Th1-mediated autoimmunity J Immunol 175 2005 6303 6310 (Pubitemid 41598869)
87. J.T. Rosenbaum, H.L. Rosenzweig, J.R. Smith, T.M. Martin, and S.R. Planck Uveitis secondary to bacterial products Ophthalmic Res 40 2008 165 168 (Pubitemid 351562897)
88. W. Chen, X. Hu, L. Zhao, S. Li, and H. Lu Expression of Toll-like receptor 4 in uvea-resident tissue macrophages during endotoxin-induced uveitis Mol Vis 15 2009 619 628
89. T.V. Arumugam, E. Okun, S.C. Tang, J. Thundyil, S.M. Taylor, and T.M. Woodruff Toll-like receptors in ischemia-reperfusion injury Shock 32 2009 4 16
90. S. Ben Mkaddem, E. Pedruzzi, C. Werts, N. Coant, M. Bens, and F. Cluzeaud Heat shock protein gp96 and NAD(P)H oxidase 4 play key roles in Toll-like receptor 4-activated apoptosis during renal ischemia/reperfusion injury Cell Death Differ 17 2010 1474 1485
91. J.S. Park, D. Svetkauskaite, Q. He, J.Y. Kim, D. Strassheim, and A. Ishizaka Involvement of Toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein J Biol Chem 279 2004 7370 7377 (Pubitemid 38294612)
92. A. Tsung, J.R. Klune, X. Zhang, G. Jeyabalan, Z. Cao, and X. Peng HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling J Exp Med 204 2007 2913 2923 (Pubitemid 350179560)
93. Y. Li, M. Xiang, Y. Yuan, G. Xiao, J. Zhang, and Y. Jiang Hemorrhagic shock augments lung endothelial cell activation: role of temporal alterations of TLR4 and TLR2 Am J Physiol Regul Integr Comp Physiol 297 2009 R1670 R1680
94. J. Qiu, J. Xu, Y. Zheng, Y. Wei, X. Zhu, and E.H. Lo High-mobility group box 1 promotes metalloproteinase-9 upregulation through Toll-like receptor 4 after cerebral ischemia Stroke 41 2010 2077 2082
95. H. Xu, Z. Su, J. Wu, M. Yang, J.M. Penninger, and C.M. Martin The alarmin cytokine, high mobility group box 1, is produced by viable cardiomyocytes and mediates the lipopolysaccharide-induced myocardial dysfunction via a TLR4/phosphatidylinositol 3-kinase gamma pathway J Immunol 184 2010 1492 1498
96. S. Hagiwara, H. Iwasaka, A. Hasegawa, N. Asai, T. Uchida, and T. Noguchi Dendritic cell activation in response to ischemia-reperfusion injury of the small intestine Surg Today 40 2010 137 145
97. B. Kruger, S. Krick, N. Dhillon, S.M. Lerner, S. Ames, and J.S. Bromberg Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation Proc Natl Acad Sci U S A 106 2009 3390 3395
98. D.J. Kaczorowski, A. Nakao, R. Vallabhaneni, K.P. Mollen, R. Sugimoto, and J. Kohmoto Mechanisms of Toll-like receptor 4 (TLR4)-mediated inflammation after cold ischemia/reperfusion in the heart Transplantation 87 2009 1455 1463
99. Q.W. Yang, F.L. Lu, Y. Zhou, L. Wang, Q. Zhong, and S. Lin HMBG1 mediates ischemia-reperfusion injury by TRIF-adaptor independent Toll-like receptor 4 signaling J Cereb Blood Flow Metab 31 2011 593 605
100. Y. Gao, X. Fang, H. Sun, Y. Wang, L.J. Yao, and J.P. Li Toll-like receptor 4-mediated myeloid differentiation factor 88-dependent signaling pathway is activated by cerebral ischemia-reperfusion in hippocampal CA1 region in mice Biol Pharm Bull 32 2009 1665 1671
101. K. Hyakkoku, J. Hamanaka, K. Tsuruma, M. Shimazawa, H. Tanaka, and S. Uematsu Toll-like receptor 4 (TLR4), but not TLR3 or TLR9, knock-out mice have neuroprotective effects against focal cerebral ischemia Neuroscience 171 2010 258 267
102. F. Hua, J. Ma, T. Ha, J.L. Kelley, R.L. Kao, and J.B. Schweitzer Differential roles of TLR2 and TLR4 in acute focal cerebral ischemia/reperfusion injury in mice Brain Res 1262 2009 100 108
103. J.D. Ellett, Z.P. Evans, C. Atkinson, M.G. Schmidt, R.G. Schnellmann, and K.D. Chavin Toll-like receptor 4 is a key mediator of murine steatotic liver warm ischemia/reperfusion injury Liver Transpl 15 2009 1101 1109
104. Y. Uchida, B. Ke, M.C. Freitas, H. Yagita, H. Akiba, and R.W. Busuttil T-cell immunoglobulin mucin-3 determines severity of liver ischemia/reperfusion injury in mice in a TLR4-dependent manner Gastroenterology 139 2010 2195 2206
105. R. Dhupar, J.R. Klune, J. Evankovich, J. Cardinal, M. Zhang, M. Ross, N. Murase, D.A. Geller, T.R. Billiar, and A. Tsung Interferon regulatory factor-1 mediates acetylation and release of high mobility group box-1 from hepatocytes during murine liver ischemia-reperfusion injury Shock 35 2011 293 301
106. M. Liu, M. Gu, D. Xu, Q. Lv, W. Zhang, and Y. Wu Protective effects of Toll-like receptor 4 inhibitor eritoran on renal ischemia-reperfusion injury Transplant Proc 42 2010 1539 1544
107. P.M. Tatum Jr., C.M. Harmon, R.G. Lorenz, and R.A. Dimmitt Toll-like receptor 4 is protective against neonatal murine ischemia-reperfusion intestinal injury J Pediatr Surg 45 2010 1246 1255
108. G. Zanotti, M. Casiraghi, J.B. Abano, J.R. Tatreau, M. Sevala, and H. Berlin Novel critical role of Toll-like receptor 4 in lung ischemia-reperfusion injury and edema Am J Physiol Lung Cell Mol Physiol 297 2009 L52 L63
109. G. Dvoriantchikova, D.J. Barakat, E. Hernandez, V.I. Shestopalov, and D. Ivanov Toll-like receptor 4 contributes to retinal ischemia/reperfusion injury Mol Vis 16 2010 1907 1912
110. M. Lv, Y. Liu, J. Zhang, L. Sun, Z. Liu, S. Zhang, B. Wang, D. Su, and Z. Su Roles of inflammation response in microglia cell through Toll-like receptors 2/interleukin-23/interleukin-17 pathway in cerebral ischemia/reperfusion injury Neuroscience 176 2011 162 172
111. T. Abe, M. Shimamura, K. Jackman, H. Kurinami, J. Anrather, and P. Zhou Key role of CD36 in Toll-like receptor 2 signaling in cerebral ischemia Stroke 41 2010 898 904
112. J. Mersmann, R. Berkels, P. Zacharowski, N. Tran, A. Koch, and K. Iekushi Preconditioning by Toll-like receptor 2 agonist Pam3CSK4 reduces CXCL1-dependent leukocyte recruitment in murine myocardial ischemia/reperfusion injury Crit Care Med 38 2010 903 909
113. A.M. Abarbanell, Y. Wang, J.L. Herrmann, B.R. Weil, J.A. Poynter, and M.C. Manukyan Toll-like receptor 2 mediates mesenchymal stem cell-associated myocardial recovery and VEGF production following acute ischemia-reperfusion injury Am J Physiol Heart Circ Physiol 298 2010 H1529 H1536
114. J. Mersmann, K. Habeck, K. Latsch, R. Zimmermann, C. Jacoby, and J.W. Fischer Left ventricular dilation in Toll-like receptor 2 deficient mice after myocardial ischemia/reperfusion through defective scar formation Basic Res Cardiol 106 2011 89 98
115. J. Mersmann, A. Koch, N. Tran, R. Zimmermann, T.F. Granja, and J. Larmann Toll-like receptor 2 signaling triggers fatal arrhythmias upon myocardial ischemia-reperfusion Crit Care Med 38 2010 1927 1932
116. F. Arslan, M.B. Smeets, L.A. O'Neill, B. Keogh, P. McGuirk, and L. Timmers Myocardial ischemia/reperfusion injury is mediated by leukocytic Toll-like receptor-2 and reduced by systemic administration of a novel anti-Toll-like receptor-2 antibody Circulation 121 2011 80 90
117. U. Hoffmann, T. Bergler, M. Rihm, C. Pace, B. Kruger, B. Jung, S.W. Reinhold, S. Farkas, P. Rummele, B.K. Kramer, and B. Banas Impact of Toll-like receptor 2 expression in renal allograft rejection Nephrol Dial Transplant 26 2011 1080 1087
118. Z.M. Bamboat, V.P. Balachandran, L.M. Ocuin, H. Obaid, G. Plitas, and R.P. DeMatteo Toll-like receptor 9 inhibition confers protection from liver ischemia-reperfusion injury Hepatology 51 2010 621 632
119. L. Macedo, G. Pinhal-Enfield, V. Alshits, G. Elson, B.N. Cronstein, and S.J. Leibovich Wound healing is impaired in MyD88-deficient mice: a role for MyD88 in the regulation of wound healing by adenosine A2A receptors Am J Pathol 171 2007 1774 1788
120. M.R. Dasu, R.K. Thangappan, A. Bourgette, L.A. DiPietro, R. Isseroff, and I. Jialal TLR2 expression and signaling-dependent inflammation impair wound healing in diabetic mice Lab Invest 90 2010 1628 1636
121. T. Sato, M. Yamamoto, T. Shimosato, and D.M. Klinman Accelerated wound healing mediated by activation of Toll-like receptor 9 Wound Repair Regen 18 2010 586 593
122. J. Gregorio, S. Meller, C. Conrad, A. Di Nardo, B. Homey, and A. Lauerma Plasmacytoid dendritic cells sense skin injury and promote wound healing through type I interferons J Exp Med 207 2010 2921 2930
123. Y. Lai, A. Di Nardo, T. Nakatsuji, A. Leichtle, Y. Yang, and A.L. Cogen Commensal bacteria regulate Toll-like receptor 3-dependent inflammation after skin injury Nat Med 15 2009 1377 1382
124. Q. Lin, D. Fang, J. Fang, X. Ren, X. Yang, F. Wen, and S.B. Su Impaired wound healing with defective expression of chemokines and recruitment of myeloid cells in TLR3-deficient mice J Immunol 186 2011 3710 3717
125. M. Vijay-Kumar, H. Wu, J. Aitken, V.L. Kolachala, A.S. Neish, and S.V. Sitaraman Activation of Toll-like receptor 3 protects against DSS-induced acute colitis Inflamm Bowel Dis 13 2007 856 864 (Pubitemid 47203863)
126. M. Fukata, L. Shang, R. Santaolalla, J. Sotolongo, C. Pastorini, and C. Espana Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesis Inflamm Bowel Dis 2010
127. D. Hsu, M. Fukata, Y.G. Hernandez, J.P. Sotolongo, T. Goo, and J. Maki Toll-like receptor 4 differentially regulates epidermal growth factor-related growth factors in response to intestinal mucosal injury Lab Invest 90 2010 1295 1305
128. D.K. Podolsky, G. Gerken, A. Eyking, and E. Cario Colitis-associated variant of TLR2 causes impaired mucosal repair because of TFF3 deficiency Gastroenterology 137 2009 209 220
129. X. Zhang, C. Zhu, D. Wu, and X. Jiang Possible role of Toll-like receptor 4 in acute pancreatitis Pancreas 39 2010 819 824
130. R. Sharif, R. Dawra, K. Wasiluk, P. Phillips, V. Dudeja, and E. Kurt-Jones Impact of Toll-like receptor 4 on the severity of acute pancreatitis and pancreatitis-associated lung injury in mice Gut 58 2009 813 819
131. Q.Z. Shi, L.W. Wang, W. Zhang, and Z.J. Gong Betaine inhibits Toll-like receptor 4 expression in rats with ethanol-induced liver injury World J Gastroenterol 16 2010 897 903
132. J. Petrasek, A. Dolganiuc, T. Csak, B. Nath, I. Hritz, and K. Kodys Interferon regulatory factor 3 and type I interferons are protective in alcoholic liver injury in mice by way of crosstalk of parenchymal and myeloid cells Hepatology 53 2010 649 660
133. T. Csak, A. Velayudham, I. Hritz, J. Petrasek, I. Levin, D. Lippai, D. Catalano, P. Mandrekar, A. Dolganiuc, E. Kurt-Jones, and G. Szabo Deficiency in myeloid differentiation factor-2 and Toll-like receptor 4 expression attenuates non-alcoholic steatohepatitis and fibrosis in mice Am J Physiol Gastrointest Liver Physiol 300 2011 G433 G441
134. J. Petrasek, A. Dolganiuc, T. Csak, E.A. Kurt-Jones, and G. Szabo Type I interferons protect from Toll-like receptor 9-associated liver injury and regulate IL-1 receptor antagonist in mice Gastroenterology 140 2011 697 708 e4.
135. M.D. Bird, A. Zahs, C. Deburghgraeve, L. Ramirez, M.A. Choudhry, and E.J. Kovacs Decreased pulmonary inflammation following ethanol and burn injury in mice deficient in TLR4 but not TLR2 signaling Alcohol Clin Exp Res 34 2010 1733 1741
136. Z. He, Y. Zhu, and H. Jiang Inhibiting Toll-like receptor 4 signaling ameliorates pulmonary fibrosis during acute lung injury induced by lipopolysaccharide: an experimental study Respir Res 10 2009 126
137. H. Li, X. Su, X. Yan, K. Wasserloos, W. Chao, and A.M. Kaynar Toll-like receptor 4-myeloid differentiation factor 88 signaling contributes to ventilator-induced lung injury in mice Anesthesiology 113 2010 619 629
138. J.C. Leemans, L.M. Butter, W.P. Pulskens, G.J. Teske, N. Claessen, and T. van der Poll The role of Toll-like receptor 2 in inflammation and fibrosis during progressive renal injury PLoS One 4 2009 e5704
139. W.P. Pulskens, E. Rampanelli, G.J. Teske, L.M. Butter, N. Claessen, and I.K. Luirink TLR4 promotes fibrosis but attenuates tubular damage in progressive renal injury J Am Soc Nephrol 21 2010 1299 1308
140. S. Alfonso-Loeches, M. Pascual-Lucas, A.M. Blanco, I. Sanchez-Vera, and C. Guerri Pivotal role of TLR4 receptors in alcohol-induced neuroinflammation and brain damage J Neurosci 30 2010 8285 8295
141. A.S. Maharjan, D. Pilling, and R.H. Gomer Toll-like receptor 2 agonists inhibit human fibrocyte differentiation Fibrogenesis Tissue Repair 3 2010 23
142. J. Fan, Y. Li, R.M. Levy, J.J. Fan, D.J. Hackam, and Y. Vodovotz Hemorrhagic shock induces NAD(P)H oxidase activation in neutrophils: role of HMGB1-TLR4 signaling J Immunol 178 2007 6573 6580 (Pubitemid 46717441)
143. B. Lv, H. Wang, Y. Tang, Z. Fan, X. Xiao, and F. Chen High-mobility group box 1 protein induces tissue factor expression in vascular endothelial cells via activation of NF-kappaB and Egr-1 Thromb Haemost 102 2009 352 359
144. S. Dai, C. Sodhi, S. Cetin, W. Richardson, M. Branca, and M.D. Neal Extracellular high mobility group box-1 (HMGB1) inhibits enterocyte migration via activation of Toll-like receptor-4 and increased cell-matrix adhesiveness J Biol Chem 285 2010 4995 5002
145. M. Maroso, S. Balosso, T. Ravizza, J. Liu, E. Aronica, and A.M. Iyer Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures Nat Med 16 2010 413 419
146. D. Mittal, F. Saccheri, E. Venereau, T. Pusterla, M.E. Bianchi, and M. Rescigno TLR4-mediated skin carcinogenesis is dependent on immune and radioresistant cells EMBO J 29 2010 2242 2252
147. C. Sodhi, R.M. Levy, R. Gill, M. Neal, W. Richardson, M. Branca, A. Russo, T. Prindle, T.R. Billiar, and D.J. Hackam DNA attenuates enterocyte Toll-like receptor 4-mediated intestinal mucosal injury after remote trauma Am J Physiol Gastrointest Liver Physiol 300 2011 G862 G873
148. J.R. van Beijnum, W.A. Buurman, and A.W. Griffioen Convergence and amplification of Toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1) Angiogenesis 11 2008 91 99
149. F. Wang, Z. Lu, M. Hawkes, H. Yang, K.C. Kain, and W.C. Liles Fas (CD95) induces rapid, TLR4/IRAK4-dependent release of pro-inflammatory HMGB1 from macrophages J Inflamm (Lond) 7 2010 30
150. H. Yang, H.S. Hreggvidsdottir, K. Palmblad, H. Wang, M. Ochani, and J. Li A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release Proc Natl Acad Sci U S A 107 2010 11942 11947
151. Q. Lin, X.P. Yang, D. Fang, X. Ren, H. Zhou, J. Fang, X. Liu, S. Zhou, F. Wen, X. Yao, J.M. Wang, and S.B. Su High-mobility group box-1 mediates Toll-like receptor 4-dependent angiogenesis Arterioscler Thromb Vasc Biol 31 2011 1024 1032
152. D. de Groot, I.E. Hoefer, S. Grundmann, A. Schoneveld, R.T. Haverslag, and J.K. van Keulen Arteriogenesis requires Toll-like receptor 2 and 4 expression in bone-marrow derived cells J Mol Cell Cardiol 50 2011 25 32
153. X.Z. West, N.L. Malinin, A.A. Merkulova, M. Tischenko, B.A. Kerr, and E.C. Borden Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands Nature 467 2010 972 976
154. J.E. Cole, T.J. Navin, A.J. Cross, M.E. Goddard, L. Alexopoulou, and A.T. Mitra From the cover: unexpected protective role for Toll-like receptor 3 in the arterial wall Proc Natl Acad Sci U S A 108 2011 2372 2377
155. S.A. Summers, O.M. Steinmetz, P.Y. Gan, J.D. Ooi, D. Odobasic, A. Kitching, and S.R. Holdsworth TLR2 induces Th17 myeloperoxidase autoimmunity, while TLR9 drives Th1 autoimmunity Arthritis Rheum 63 2011 1124 1135
156. S. Garantziotis, Z. Li, E.N. Potts, J.Y. Lindsey, V.P. Stober, and V.V. Polosukhin TLR4 is necessary for hyaluronan-mediated airway hyperresponsiveness after ozone inhalation Am J Respir Crit Care Med 181 2010 666 675
157. K.C. Young, S.M. Hussein, R. Dadiz, D. deMello, C. Devia, D. Hehre, and C. Suguihara Toll-like receptor 4-deficient mice are resistant to chronic hypoxia-induced pulmonary hypertension Exp Lung Res 36 2010 111 119
158. X.Q. Shi, H. Zekki, and J. Zhang The role of TLR2 in nerve injury-induced neuropathic pain is essentially mediated through macrophages in peripheral inflammatory response Glia 59 2011 231 241
159. F.X. Wu, J.J. Bian, X.R. Miao, S.D. Huang, X.W. Xu, and D.J. Gong Intrathecal siRNA against Toll-like receptor 4 reduces nociception in a rat model of neuropathic pain Int J Med Sci 7 2010 251 259
160. Y. Doi, T. Mizuno, Y. Maki, S. Jin, H. Mizoguchi, and M. Ikeyama Microglia activated with the Toll-like receptor 9 ligand CpG attenuate oligomeric amyloid beta neurotoxicity in in vitro and in vivo models of Alzheimer's disease Am J Pathol 175 2009 2121 2132
161. G.Y. Chen, and G. Nunez Sterile inflammation: sensing and reacting to damage Nat Rev Immunol 10 2010 826 837
162. S. Abdollahi-Roodsaz, L.A. Joosten, M.I. Koenders, I. Devesa, M.F. Roelofs, and T.R. Radstake Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis J Clin Invest 118 2008 205 216
163. S. Fasciano, and L. Li Intervention of Toll-like receptor-mediated human innate immunity and inflammation by synthetic compounds and naturally occurring products Curr Med Chem 13 2006 1389 1395
164. L. Alexopoulou, A.C. Holt, R. Medzhitov, and R.A. Flavell Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3 Nature 413 2001 732 738 (Pubitemid 33009951)
165. E. Andersen-Nissen, K.D. Smith, R. Bonneau, R.K. Strong, and A. Aderem A conserved surface on Toll-like receptor 5 recognizes bacterial flagellin J Exp Med 204 2007 393 403 (Pubitemid 46294554)
166. U. Hasan, C. Chaffois, C. Gaillard, V. Saulnier, E. Merck, and S. Tancredi Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88 J Immunol 174 2005 2942 2950 (Pubitemid 40279713)
167. F. Heil, H. Hemmi, H. Hochrein, F. Ampenberger, C. Kirschning, and S. Akira Species-specific recognition of single-stranded RNA via Toll-like receptor 7 and 8 Science 303 2004 1526 1529 (Pubitemid 38314424)
168. H. Hemmi, T. Kaisho, O. Takeuchi, S. Sato, H. Sanjo, and K. Hoshino Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway Nat Immunol 3 2002 196 200 (Pubitemid 34141451)
169. H. Hemmi, O. Takeuchi, T. Kawai, T. Kaisho, S. Sato, and H. Sanjo A Toll-like receptor recognizes bacterial DNA Nature 408 2000 740 745 (Pubitemid 32015992)
170. M. Jurk, F. Heil, J. Vollmer, C. Schetter, A.M. Krieg, and H. Wagner Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848 Nat Immunol 3 2002 499 (Pubitemid 34669818)
171. S. Ivanov, A.M. Dragoi, X. Wang, C. Dallacosta, J. Louten, and G. Musco A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA Blood 110 2007 1970 1981 (Pubitemid 47443911)